(Report) 45th Breakfast Meeting
date : 9/19/2013
In May 2013, as a result of how the Hollywood actress Angelina Jolie had boldly shared her experience which she explained of how and why she had underwent mastectomy to prevent the risk of developing breast cancer in the future when she found that mutations in the BRCA1 gene were detected in the genetic testing of hereditary breast ovarian cancer via New York Times The Opinion Pages, the news had turned into a hot topic in Japan.
At almost the same time, “New prenatal diagnosis” was available for the pregnant women to determine the presence of chromosomal abnormalities in fetal blood test in April this year. As the genetic analysis technology advances, examining and predicting future disease of the baby through fetal genetic testing is made possible. However, this has also accompanied with difficult choices to make. Fear is also voiced as the technology may lead to discrimination of people with possible diseases.
We invited Chieko Tamura, the only person in Japan who holds both American and Japanese certificates as a genetic counselor to share with us the current situation and challenges of genetic counseling and genetic testing.
“Why did Angelina Jolie undergo the surgery? – a perspective of a certified genetic counselor from both Japan and the United States with regards to the current situation and challenges of genetic counseling and genetic testing.”
Chieko Tamura originally studied pharmaceutical science, and has a Japanese national license as a pharmacist, since 1988. After working for a pharmaceutical company for thirteen years as a basic and clinical research scientist and a product manager, she went to the U.S.A. as a Fulbright scholar and studied genetic counseling at the joint graduate program of the National Human Genome Research Institute and Johns Hopkins University School of Public Health, and graduated in 2003 getting the master’s degree. She has been certified as a genetic counselor by the American Board of Genetic Counseling as well as the Japanese Board of Genetic Counseling. She is currently the only person who holds both American and Japanese certificates as a genetic counselor, and is now a board member of the Japanese Association of Certified Genetic Counselors. After returning to Japan in 2003, she worked as a genetic counselor, at many different medical institutions, including the Japan’s National Center for Child Health and Development, several university hospitals and major fertility clinics, covering a variety of conditions, including prenatal, pediatrics, adult genetics, cancer genetics, neurogenetics, and infertility, etc. Ms. Tamura also worked as an associate professor for five years at one of the newly established genetic counseling training graduate programs at Ochanomizu University in Tokyo. She has been working as an advisor to several patient and family support groups, with Marfan syndrome, Turner syndrome, prion diseases, familial colon cancer, spinocerebellar ataxia, etc.
■Date and Time
Sep 19, 2013 8:00am-9:00am
GARB Marunouchi （2-2-3 Marunouchi, Chiyoda-ku, Tokyo）
Top Research & Recommendations Posts
- [Publication Report] Planetary Health Promotion Project “Issues Facing Planetary Health and the Role of the Health Sector” (May 10, 2023)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022）
- [Policy Recommendations] Building a Research and Development System Together With People Living with Dementia and Their Families to Drive Parallel Progress in Creating an Inclusive Society and Advancing R&D (April 25, 2023)
- [Public Comment Submission] Opinions Regarding the Proposed “National Action Plan on Antimicrobial Resistance 2023-2027 (Draft)” (March 16, 2023)
- [Recommendations] Recommendations for the G7 Hiroshima Summit in 2023 Necessary Actions for AMR Control, Starting with the Introduction of Pull Incentives (August 29, 2022)
- [Policy Recommendations] Recommendations for the G7 Hiroshima Summit by the C7 Global Health Working Group (April 20, 2023)
- [Policy Recommendations] Requests for the G7 Hiroshima Summit and Related Ministerial Meetings: Promoting Measures for Climate Change and Planetary Health That Keep Pace With the International Community (December 19, 2022)
- [Research Report] The Public Opinion Survey on Mental Health (August 12, 2022)
- [Recommendations] Restructuring Diagnostic Services and Achieving the Necessary Innovation to Promote AMR Control (May 26, 2023)
[Event Report] Recommendations to Prime Minister Fumio Kishida on the issue of antimicrobial resistance (AMR) in the G7 Hiroshima Summit Leaders’ Declaration (April 28, 2023)
[Event Report] (Live Broadcasting) A Dementia Symposium Commemorating the G7 Health Ministers’ Meeting in Nagasaki “Collaboration in the International Community for Advancing Dementia Measures in a New Era” (May 14, 2023)
[Event Report] A NAGASAKI Planetary Health Expert Meeting “From COP27 and COP15 to the G7 Hiroshima Summit: New Partnerships for Solving Climate, Environment, Biodiversity and Health Issues” (May 12, 2023)
[RegistrationOpen] Health Policy Academy the 12th Session
[Recommendations] Restructuring Diagnostic Services and Achieving the Necessary Innovation to Promote AMR Control (May 26, 2023)